Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin

Roger Li; Scott M. Gilbert; Ashish M. Kamat

doi:10.1016/j.eururo.2020.08.027

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin

Roger Li, Scott M. Gilbert, Ashish M. Kamat

Urology

Research output: Contribution to journal › Editorial › peer-review

8 Scopus citations

Abstract

Our understanding of the mechanism of bacillus Calmette-Guérin (BCG) in controlling urothelial carcinoma is still evolving. Studies have revealed a complex and multifaceted immune response. BCG-elicited adaptive antitumor immunity directed towards tumor antigens could have major implications for trial design.

Original language	English (US)
Pages (from-to)	1-3
Number of pages	3
Journal	European urology
Volume	80
Issue number	1
DOIs	https://doi.org/10.1016/j.eururo.2020.08.027
State	Published - Jul 2021

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2020.08.027

Cite this

@article{9c2b1746fd1d478f98e752bf487f2861,

title = "Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Gu{\'e}rin",

abstract = "Our understanding of the mechanism of bacillus Calmette-Gu{\'e}rin (BCG) in controlling urothelial carcinoma is still evolving. Studies have revealed a complex and multifaceted immune response. BCG-elicited adaptive antitumor immunity directed towards tumor antigens could have major implications for trial design.",

author = "Roger Li and Gilbert, {Scott M.} and Kamat, {Ashish M.}",

year = "2021",

month = jul,

doi = "10.1016/j.eururo.2020.08.027",

language = "English (US)",

volume = "80",

pages = "1--3",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin

AU - Li, Roger

AU - Gilbert, Scott M.

AU - Kamat, Ashish M.

PY - 2021/7

Y1 - 2021/7

N2 - Our understanding of the mechanism of bacillus Calmette-Guérin (BCG) in controlling urothelial carcinoma is still evolving. Studies have revealed a complex and multifaceted immune response. BCG-elicited adaptive antitumor immunity directed towards tumor antigens could have major implications for trial design.

AB - Our understanding of the mechanism of bacillus Calmette-Guérin (BCG) in controlling urothelial carcinoma is still evolving. Studies have revealed a complex and multifaceted immune response. BCG-elicited adaptive antitumor immunity directed towards tumor antigens could have major implications for trial design.

UR - http://www.scopus.com/inward/record.url?scp=85089902674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089902674&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2020.08.027

DO - 10.1016/j.eururo.2020.08.027

M3 - Editorial

C2 - 32861573

AN - SCOPUS:85089902674

SN - 0302-2838

VL - 80

SP - 1

EP - 3

JO - European urology

JF - European urology

IS - 1

ER -

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this